GPGrossPatternRESEARCH SYSTEM
SEC CHECK STALE
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ASRV · Dec 31, 2024

AMERISERV FINANCIAL INC /PA/. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-25-003291Bank
Sequential deposit growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

0.98% · CORE · VALID

Interest-expense growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_expense

22.61% · CORE · VALID

Interest-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

9.28% · CORE · VALID

Cash and equivalents15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$17.7M · CORE · VALID

Sequential loan growth85thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

2.81% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History59 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
1.62%
Current
0.98%
Delta
-0.64%
Funding Cost Growth Increased
Previous
17.79%
Current
22.61%
Delta
4.83%
Interest Income Growth Increased
Previous
8.22%
Current
9.28%
Delta
1.06%
Liquidity Decreased
Previous
$22.1M
Current
$17.7M
Delta
-$4.4M
Loan Growth Increased
Previous
0.08%
Current
2.81%
Delta
2.73%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.